Gentamicin sulfate eye drops 3 mg/ml 5 ml with dropper cap No. 1


Compound

The solution for intravenous and intramuscular administration contains the active component gentamicin sulfate , as well as a number of additional components: sodium metabisulfite, disodium ethylenediaminetetraacetic acid, water.
Eye drops contain the active component gentamicin sulfate , as well as additional components: sodium dihydrogen phosphate monohydrate, sodium chloride, sodium hydrogen phosphate dodecahydrate, benzalkonium chloride solution, water.

pharmachologic effect

Gentamicin is an antibiotic that exhibits a wide spectrum of effects and belongs to the group of aminoglycosides. In the body, it binds to the 30S subunit of ribosomes, as a result of which protein synthesis is disrupted and the production of the transport and messenger RNA complex is suspended. RNA is misread and nonfunctional proteins are produced. A bactericidal effect is observed - at high concentrations of the substance, it reduces the barrier functions of cytoplasmic membranes, as a result of which microorganisms die.

There is a high sensitivity to this antibiotic on the part of some gram-negative microorganisms.

Sensitivity to the substance of a number of gram-positive microorganisms was also noted.

Antibiotic resistance is demonstrated by: Neisseria meningitidis, Providencia rettgeri, Clostridium spp., Treponema pallidum, Bacteroides spp., Streptococcus spp.

If Gentamicin is combined with penicillins , its activity is noted against Enterococcus faecium, Enterococcus faecalis, Enterococcus avium, Enterococcus durans, Streptococcus faecium, Streptococcus durans, Streptococcus faecalis.

Resistance of microorganisms to this drug develops slowly, but those strains that demonstrate resistance to neomycin and kanamycin may also be resistant to the effects of gentamicin. It has no effect on fungi, protozoa, or viruses.

Pharmacokinetics and pharmacodynamics

After intramuscular administration, rapid and complete absorption of the substance occurs. The maximum concentration in the body after intramuscular administration is achieved after 0.5-1.5 hours. After a 30-minute intravenous infusion - after 30 minutes, after a 60-minute intravenous infusion - after 15 minutes.

Little binds to plasma proteins - up to 10%. Therapeutic concentrations of the substance are found in the kidneys, liver, lungs, as well as in body fluids - peritoneal, ascitic, synovial, pericardial, pleural, lymphatic; found in pus discharged from wounds, granulations, and urine.

Low concentrations of the substance are observed in muscles, adipose tissue, breast milk, bile, bones, sputum, bronchial secretions, cerebrospinal fluid, and eye moisture.

It almost does not penetrate the BBB in adult patients; it penetrates the placenta.

Concentrations in the cerebrospinal fluid of newborns are higher than in adults.

It is not metabolized in the body. The half-life in adults is 2-4 hours, in children under 6 months - 3-3.5 hours.

It is mainly excreted from the body through the kidneys, unchanged; small amounts of the antibiotic are excreted in the bile. If the patient’s kidney function is normal, then during the first day 70-95% of the substance is excreted. In this case, a concentration of more than 100 mcg/ml is observed in the urine. Cumulation is observed upon repeated administration.

Pharmacological properties of the drug Gentamicin sulfate

Pharmacodynamics. Gentamicin is an aminoglycoside antibiotic with a broad spectrum of action. The mechanism of action is associated with inhibition of 30S ribosomal subunits. In vitro tests confirm its activity against different types of gram-positive and gram-negative microorganisms: Escherichia coli, Proteus spp. (indole-positive and indole-negative), Pseudomonas aeruginosa, Klebsiella spp., Enterobacter spp., Citrobacter spp., Salmonella spp., Shigella spp. and Staphylococcus spp . (including penicillin- and methicillin-resistant strains). The following microorganisms are generally resistant to gentamicin: Streptococcus pneumoniae , most other streptococcal species, enterococci, Neisseria meningitides, Treponema pallidum and anaerobic microorganisms such as Baacteroides spp . or Clostridium spp . Pharmacokinetics . Gentamicin is easily absorbed, reaching maximum plasma concentrations 30–60 minutes after intramuscular administration. Therapeutic concentrations in the blood remain for 6–8 hours. With intravenous drip administration, the concentration of the antibiotic in the blood plasma during the first hours exceeds the concentration achieved after intramuscular administration of the drug. Plasma protein binding is 0–10%. In therapeutic concentrations it is determined in kidney tissue, lungs, pleural and peritoneal exudates. Normally, gentamicin, when administered parenterally, penetrates the BBB poorly, but with meningitis, the concentration in the CSF increases. The drug passes into breast milk. About 70% of gentamicin is excreted unchanged into the urine during the day by glomerular filtration. The half-life from blood plasma is approximately 2 hours. If the excretory function of the kidneys is impaired, the concentration and half-life of gentamicin increases significantly.

Indications for use

Indications for use of the drug are diseases of an infectious-inflammatory nature that were provoked by microorganisms sensitive to gentamicin.

Parenteral use of the drug (4% solution) is indicated for the following diseases:

  • pyelonephritis;
  • acute cholecystitis ;
  • cholangitis;
  • cystitis;
  • pneumonia;
  • peritonitis;
  • pleural empyema;
  • ventriculitis;
  • sepsis, purulent lesions of soft tissues and skin;
  • infections due to wounds and burns;
  • infections of joints and bones.

Injections in gynecology are used for severe inflammatory processes.

External use of the drug (Gentamicin ointment) is indicated for the following diseases:

  • superficial folliculitis;
  • pyoderma;
  • furunculosis;
  • seborrheic dermatitis infected;
  • paronychia;
  • sycosis;
  • acne infected;
  • manifestation of secondary bacterial infection in the case of viral and fungal diseases of the skin;
  • wounds of various origins (bites, burns, ulcers, etc.);
  • Infected varicose ulcers.

Local use of Gentamicin (eye drops) is advisable for the following diseases:

  • blepharoconjunctivitis;
  • blepharitis;
  • conjunctivitis;
  • meibomite;
  • keratitis;
  • keratoconjunctivitis;
  • dacryocystitis.

Nosological classification (ICD-10)

  • A09 Diarrhea and gastroenteritis of presumably infectious origin (dysentery, bacterial diarrhea)
  • A41.9 Septicemia, unspecified
  • J06 Acute upper respiratory tract infections of multiple and unspecified localization
  • J18 Pneumonia without specifying the pathogen
  • J22 Acute respiratory infection of the lower respiratory tract, unspecified
  • J40 Bronchitis, not specified as acute or chronic
  • J85 Abscess of the lung and mediastinum
  • J86 Pyothorax
  • K65 Peritonitis
  • L00-L08 Infections of the skin and subcutaneous tissue
  • L02 Skin abscess, boil and carbuncle
  • L08.0 Pyoderma
  • M00-M03 Infectious arthropathy
  • M60.0 Infectious myositis
  • M65.0 Tendon sheath abscess
  • M65.1 Other infectious tenosynovitis
  • M71.0 Abscess of bursa
  • M71.1 Other infectious bursitis
  • M86 Osteomyelitis
  • N15 Other tubulointerstitial kidney diseases
  • N39.0 Urinary tract infection without established location
  • O85 Puerperal sepsis
  • O86 Other postpartum infections
  • R09.1 Pleurisy
  • R78.8.0* Bacteremia
  • T79.3 Post-traumatic wound infection, not elsewhere classified

Side effects

During administration, certain side effects may occur:

  • digestive system: hyperbilirubinemia, nausea and vomiting, increased activity of “liver” transaminases;
  • hematopoiesis: leukopenia , anemia, thrombocytopenia, granulocytopenia;
  • nervous system: paresthesia , headache, muscle twitching, numbness, epileptic seizures, drowsiness ; possible manifestation of psychosis in children;
  • sense organs: tinnitus, hearing loss, labyrinthine and vestibular disorders, deafness;
  • urination: nephrotoxicity with impaired renal function, rarely - renal tubular necrosis ;
  • allergies: skin rash, fever , itching, eosinophilia, angioedema;
  • laboratory parameters: hypokalemia, hypocalcemia, hypomagnesemia - in children;
  • other manifestations: superinfection.

Instructions for use of Gentamicin (Method and dosage)

to use gentamicin sulfate , taking into account the location of the infection, the severity of the disease, and the sensitivity of the pathogen.

Gentamicin injections, instructions for use

Before starting treatment, it is recommended to determine the sensitivity of microflora to gentamicin.

The drug in ampoules when administered intravenously or intramuscularly to adults is indicated at a dose of 1.7 mg per kg of weight. The dose per day is 3-5 mg per kg of weight. The medicine must be administered 2-4 times a day. Treatment lasts from 7 to 10 days. For intramuscular administration, the powder is also used, after adding 2 ml of distilled water to the ampoule.

Gentamicin, depending on the disease, can also be used at a dose of 120-160 mg once a day for 7-10 days or at a dose of 240-280 mg once.

Intravenous administration is carried out over 1-2 hours.

Children are prescribed this medicine only for severe infectious diseases. Newborns and premature infants receive a daily dose of 2-5 mg per kg, the drug is administered twice a day.

Children under 2 years of age receive the same dose per day, the drug is administered three times a day.

Children over 2 years of age receive a daily dose of 3-5 mg per kg, the drug is administered three times a day.

In patients with impaired renal function, the dose needs to be adjusted.

The maximum dose per day for children and adults is 5 mg per kg of weight.

Gentamicin ointment, instructions for use

Gentamicin Akos ointment should be applied externally 3-4 times a day. Before application, necrotic masses and pus should be thoroughly removed. If the lesions are extensive, then the dose of ointment per day should not exceed 200 g. The duration of treatment is determined by the doctor.

Eye drops should be instilled 1-2 drops every 1-4 hours into the lower conjunctival sac. Patients with keratitis, conjunctivitis and other infectious and inflammatory eye diseases are recommended to drip a 0.3% solution of Gentamicin three times a day.

The product is not produced in tablets.

Gentamicin sulfate eye drops 3 mg/ml 5 ml with dropper cap No. 1

Name

Gentamicin sulfate.

Description

GENTAMICIN SULFATE, solution (eye drops) 3 mg/ml, is a clear, colorless or slightly yellowish solution.

Dosage

5 ml in glass bottles, sealed with rubber stoppers and rolled caps. The bottle, along with a dropper cap and a leaflet, is placed in a cardboard pack.

Release forms

Eye drops.

INN

Gentamicin.

FTG

Antibiotic; aminoglycoside

Pharmacological properties

The drug GENTAMICIN SULPHATE contains the active substance – gentamicin sulfate, which is used to treat infections caused by pathogens sensitive to it. GENTAMICIN SULFATE is intended for the treatment of the following infectious and inflammatory eye diseases: • acute and chronic conjunctivitis (inflammation of the mucous membrane of the eye); • corneal ulcer; • keratitis (inflammation of the cornea); • keratoconjunctivitis (inflammation of the cornea and conjunctiva); • acute and chronic iritis (inflammation of the iris); • acute and chronic blepharitis (inflammation of the edges of the eyelids); • blepharoconjunctivitis (inflammation of the edges of the eyelids and conjunctiva); • dacryocystitis (inflammation of the lacrimal sac of the eye). GENTAMICIN SULFATE is also used for the prevention and treatment of purulent complications after eye surgery.

Compound

One bottle contains the active ingredient: gentamicin sulfate – 15 mg; excipients: disodium edetate, solution of 60 mg/ml dextran with M.m. 50000-70000 in a solution of 9 g/l sodium chloride, water for injection.

Contraindications

Do not take the drug if: • you have hypersensitivity to the active substance or to any component of the drug (see section Composition); • you have hypersensitivity to other antibiotics from the aminoglycoside group; • You are pregnant or breastfeeding. If you are not sure whether any of the above applies to you, tell your doctor before using the drug.

Special instructions and precautions

Avoid long-term use of the drug, as this can lead to sensitization (allergic reactions) and the emergence of resistant (resistant) microorganisms. During long-term treatment, renal and hearing function should be monitored. Use in patients wearing contact lenses is not recommended. Contact lenses should be removed while treating eye infections. Contact lenses should be removed before using the drug and as soon as possible. Re-use is possible 15 minutes after applying the drug. Children Safety and effectiveness in children have not been established.

Interaction with other drugs

Tell your doctor if you are using, have recently used, or are about to use any other medications. This applies to any herbal medicines or medicines that you have purchased without a doctor's prescription. GENTAMICIN SULFATE should not be used with other drugs that have ototoxic or nephrotoxic effects. When used simultaneously with the following drugs, serious adverse reactions may develop: • diuretics such as ethacrynic acid and furosemide - increases the risk of ototoxicity, • amphotericin B, cisplatin, cyclosporine and cephalosporins - increases the risk of nephrotoxicity. GENTAMICIN SULPHATE cannot be used in combination with amphotericin, cephalosporins, erythromycin, heparin, penicillins, sodium bicarbonate and sodium sulfadiazine due to pharmaceutical incompatibility.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medicine. The use of GENTAMICIN SULFATE is contraindicated during pregnancy and lactation. During treatment with the drug, you must stop breastfeeding.

Driving vehicles and working with machinery

Use caution when driving, operating industrial equipment, or performing other hazardous work. The drug may cause blurred vision. If your vision has deteriorated, refrain from these activities.

Use of the drug

Always use this medication as directed by your doctor. If in doubt, consult your doctor. Dosage regimen Instill 1-2 drops into the lower conjunctival sac of the affected eye 4-6 times a day or more often if necessary. Severe infections may require 1-2 drops every 15-20 minutes to 1-2 hours, gradually reducing the frequency of instillation as the symptoms of the infection subside. Duration of treatment The duration of treatment is usually 2 to 3 weeks maximum. After 5-7 days, symptoms of infection usually subside. After which treatment should continue for another 2-3 days. Use in children Safety and effectiveness in children have not been established.

Recommendations for use

Before use, carefully read this section and sequentially perform the operations presented below in the text and in Figures 1-6. 1. Remove the bottle from the package. 2. If the bottle is sealed with an aluminum cap: position the scissors at an angle of 45 degrees to the cap, picking up its lower edge, with an upward movement, remove the aluminum cap along with the rubber cap (Fig. A 1-2). 3. If the bottle is sealed with an aluminum cap with a plastic lining: forcefully pull the plastic lining from the side of the cuts, lifting it vertically, then sharply pull down along the bottle to break the integrity of the cap. Remove the aluminum cap and rubber plug (Fig. B 1-2). 4. Remove the dropper from the package and place it tightly on the bottle (Fig. 3). 5. Turn the bottle vertically to remove any air bubbles and wait a few seconds. In case of a large bubble, return the bottle to its original position, and then slowly repeat the action, gently tapping the bottom of the bottle (Fig. 4). 6. Apply drops by pressing your index finger and thumb onto the pipette (Fig. 5). Do not touch the eye dropper or other surfaces as this may cause the solution to become infected. 7. Turning the bottle over, close the pipette with a special stopper (Fig. 6).

Overdose

When applied topically, it is absorbed in small quantities. Overdose is unlikely. If you think you have taken too much of the drug, rinse your eyes with water or saline and consult a doctor. If you forget to use the drug If you forget to put eye drops in, do it as quickly as possible. Do not take a double dose to make up for a missed dose. If you miss several doses, tell your doctor.

Adverse reactions

Like all medicines, GENTAMICIN SULFATE can cause side effects, although not everyone gets them. When using the drug, the following adverse reactions may occur, the frequency of which is unknown (cannot be determined based on available data): • local sensitivity, blurred vision, eye irritation, burning sensation, itching in the eyes, redness of the conjunctiva, swelling; • burning sensation, tingling, itching of the skin, dermatitis; • nephrotoxicity, acute renal failure; • allergic reactions (in rare cases). Reporting side effects If you experience any side effects, tell your doctor. This also applies to any adverse reactions that are not listed in this leaflet. You can also report adverse reactions to the information database on adverse reactions (actions) to drugs, including reports of ineffectiveness of drugs (UE Center for Expertise and Testing in Healthcare, website rceth.by). By reporting adverse reactions, you can help provide more information about the safety of the drug.

Storage conditions

Store in a place protected from light at a temperature not exceeding 25 °C. Keep out of the reach and sight of children. Store in original packaging. Shelf life – 3 years. Store the opened bottle in a place protected from light at a temperature of 15 °C to 25 °C for 14 days. Do not use after expiration date. Do not use the drug if you notice that the bottle containing the solution is damaged. Do not pour any remaining medication down the drain. Ask your pharmacist how to dispose of medications that you no longer need. These measures will protect the environment.

Vacation conditions

On prescription.

Buy Gentamicin sulfate eye drops 3 mg/ml 5 ml with dropper cap No. 1 in the pharmacy

Price for Gentamicin sulfate eye drops 3 mg/ml 5 ml with dropper cap No. 1

Instructions for use for Gentamicin sulfate eye drops 3 mg/ml 5 ml with dropper cap No. 1

Overdose

In case of an overdose of Gentamicin in ampoules or other forms of the drug, a decrease in neuromuscular conduction may be observed, up to respiratory arrest.

In case of overdose, adult patients must be administered anticholinesterase drugs ( Proserin ) and calcium supplements . Before administering proserin, the patient is administered 0.5–0.7 mg of Atropine intravenously, wait until the pulse quickens, after which proserin is administered at a dose of 1.5 mg. If there is no effect after administering such a dose, the same amount of proserin is administered again. bradycardia develops, an additional atropine injection is given.

In case of overdose in children, it is necessary to administer potassium supplements. Gentamicin sulfate is removed from the body by hemodialysis and peritoneal dialysis.

Side effects of the drug Gentamicin sulfate

Totoxicity (damage to the VIII pair of cranial nerves): a decrease in hearing acuity and damage to the vestibular apparatus may develop (with symmetrical damage to the vestibular apparatus, these disorders in some cases may even go unnoticed in the first stages). A particular risk may be caused by an extended course of treatment with gentamicin - 2-3 weeks. Nephrotoxicity: the frequency and severity of kidney damage depend on the size of a single dose, the duration of treatment and the individual characteristics of the patient, the quality of control over therapy and the simultaneous use of other nephrotoxic drugs. Kidney damage is manifested by proteinuria, azotemia, less often - oliguria, and, as a rule, is reversible. Other side effects that are rare: increased levels of serum transaminases (ALAT, AST), bilirubin, reticulocytes, as well as thrombocytopenia, granulocytopenia, anemia, decreased serum calcium levels, skin rash, urticaria, itching, fever, headache, vomiting , muscle pain. Very rarely, the following side effects occur: nausea, increased salivation, loss of appetite, weight loss, purpura, laryngeal edema, joint pain, arterial hypotension and drowsiness, possible blockade of neuromuscular conduction and respiratory depression. Pain may occur at the site of intramuscular injection of gentamicin; with intravenous administration, phlebitis and periphlebitis may develop.

Interaction

If Gentamicin injections or the use of other forms of medication are practiced simultaneously with Vancomycin , aminoglycosides , cephalosporins , ethacrynic acid , the oto- and nephrotoxic effects may increase.

If the drug is used with Indomethacin , then the clearance of Gentamicin decreases, its concentration in the blood increases and, accordingly, the toxic effect increases.

When using Gentamicin with opioid analgesics , drugs for inhalation anesthesia, the likelihood of neuromuscular blockade increases, and apnea .

The concentration of gentamicin in the blood increases if it is taken simultaneously with loop diuretics .

Drug interactions Gentamicin sulfate

Concomitant use with potent diuretics (furosemide, ethacrynic acid) should be avoided, since the latter may enhance the ototoxic and nephrotoxic effect. Impaired respiratory function may occur due to neuromuscular blockade in patients who are simultaneously prescribed muscle relaxants (succinylcholine, tubocurarine, decamethonium), anesthetics, or a history of a previous massive blood transfusion using a citrate anticoagulant. The use of calcium salts and anticholinesterase drugs can eliminate the effects of neuromuscular blockade. Simultaneous and/or sequential systemic or local use of other neuro- and/or nephrotoxic drugs, such as cisplatin, cephaloridine, aminoglycoside antibiotics, polymyxin B, colistin, vancomycin should be avoided. The risk of renal dysfunction increases with simultaneous use of indomethacin and other NSAIDs, as well as quinidine, cyclophosphamide, ganglion blockers, verapamil, and polyglucin in combination with gentamicin. Gentamicin increases the toxicity of digoxin. With the simultaneous administration of aminoglycosides and penicillins, the half-life decreases and their content in the blood serum decreases. A decrease in the half-life occurs in patients with severe renal impairment when carbenicillin is combined with gentamicin. When mixing antibiotics of the aminoglycoside group with antibiotics of the beta-lactam group (penicillins, cephalosporins) in one volume, mutual inactivation is possible. Also, gentamicin is pharmacologically incompatible with amphotericin and heparin.

special instructions

This medicine should be used with caution by people who suffer from myasthenia gravis , parkinsonism , and impaired renal function . In people with impaired renal function, as well as with prolonged use of large doses of the drug, the risk of nephrotoxicity increases. During the treatment process, it is important to monitor the condition of the vestibular and hearing aids, and renal function. It is also important to determine your hearing status. If audiometric tests are unsatisfactory, treatment is stopped.

It should be taken into account that with prolonged use of the drug externally, a resorptive effect is possible, from which Gentamicin Akos ointment and other forms of the drug should be used externally in a controlled manner.

sodium bisulfite in the solution in ampoules, the likelihood of developing allergic manifestations increases, especially in people with an allergic history.

People who take medication for the treatment of infectious and inflammatory diseases of the urinary tract are advised to drink plenty of fluids during treatment.

During therapy, microbial resistance may develop.

Special instructions for the use of Gentamicin sulfate

In patients with kidney disease, it is necessary to regularly monitor the concentration of gentamicin in the blood serum and the function of the kidneys, as well as the auditory and vestibular system. If symptoms of renal dysfunction or damage to the auditory or vestibular system appear, immediate cessation of gentamicin therapy or, in exceptional cases, dose adjustment is necessary. Gentamicin sulfate should be used with caution in patients with dehydration, botulism, parkinsonism or hypocalcemia, as well as in elderly patients. Patients with kidney disease, hearing loss, dizziness, or tinnitus are especially sensitive to gentamicin. Due to limited clinical experience, administration of the entire daily dose of gentamicin sulfate is not recommended for the following conditions:

  • burns area 20%;
  • cystofibrosis;
  • ascites;
  • endocarditis;
  • chronic renal failure using hemodialysis;
  • sepsis.

With prolonged use, the dose of the drug should ensure that the concentration of gentamicin in the blood does not exceed the maximum permissible. To do this, in patients classified as at risk, it is necessary to monitor the level of gentamicin concentration in the blood during the treatment period. During pregnancy and breastfeeding. When prescribed to women during pregnancy, gentamicin can have a harmful effect on the fetus (ototoxicity), and therefore gentamicin is prescribed to women during pregnancy only for health reasons. The drug penetrates the hematoplacental barrier and into the amniotic fluid. If a child is breastfeeding and at the same time needs to be prescribed gentamicin sulfate, the mother should either stop breastfeeding or stop taking this antibiotic. Children under 3 years of age are prescribed exclusively for health reasons. Impact on the ability to drive vehicles or operate other machinery . There is no data on the effect on the ability to drive vehicles or operate machinery. However, in some patients, the use of gentamicin sulfate in high doses may cause imbalance, accompanied by nausea and dizziness, even after treatment is discontinued.

Analogs

Level 4 ATC code matches:
Colbiocin

Tetracycline ointment

Levomycetin

Fucithalmic

Tobrex

Pharmacies offer numerous analogues of Gentamicin. These drugs are Garamicin , Gentamicin Akos , Gentamicin-Teva , Gentamicin K , Asgent , Septopa , Gentacyclol , etc. The indications and contraindications for the analogues are almost the same, but the final choice of medicine should be made by a doctor. There are also a number of drugs whose active ingredients are Betamethasone + Gentamicin + Clotrimazole .

Similar drugs:

  • Furacilin Solution for topical use
  • Lactobacterin siccum dry (Lactobacterin siccum) Lyophilisate for the preparation of solution for oral administration
  • Palin Capsule
  • Bactrim Oral suspension
  • Nitroxoline Oral tablets
  • Pancef Oral tablets
  • Nifuroxazide (Nifuroxazide) Oral tablets
  • Ercefuryl Oral suspension
  • Sextaphag Oral solution
  • Pancef Granules for the preparation of suspension for oral administration

** The Drug Directory is intended for informational purposes only. For more complete information, please refer to the manufacturer's instructions. Do not self-medicate; Before you start using Gentamicin sulfate, you should consult a doctor. EUROLAB is not responsible for the consequences caused by the use of information posted on the portal. Any information on the site does not replace medical advice and cannot serve as a guarantee of the positive effect of the drug.

Are you interested in the drug Gentamicin sulfate? Do you want to know more detailed information or do you need a doctor's examination? Or do you need an inspection? You can make an appointment with a doctor - the Euro lab is always at your service! The best doctors will examine you, advise you, provide the necessary assistance and make a diagnosis. You can also call a doctor at home . Euro lab clinic is open for you around the clock.

** Attention! The information presented in this medication guide is intended for medical professionals and should not be used as a basis for self-medication. The description of the drug Gentamicin sulfate is provided for informational purposes and is not intended for prescribing treatment without the participation of a doctor. Patients need to consult a specialist!

If you are interested in any other drugs and medications, their descriptions and instructions for use, information about the composition and form of release, indications for use and side effects, methods of use, prices and reviews of drugs, or you have any other questions and suggestions - write to us, we will definitely try to help you.

Gentamicin price, where to buy

The price of Gentamicin in ampoules is 40-50 rubles per pack. 10 ampoules. Injections can be bought at any pharmacy. The ointment costs from 60 rubles. per pack 25 g. Gentamicin eye drops can be purchased at a price of 130 rubles.

  • Online pharmacies in RussiaRussia
  • Online pharmacies in UkraineUkraine
  • Online pharmacies in KazakhstanKazakhstan

ZdravCity

  • Dexa-Gentamicin eye drops 5mlUrsapharm Arzneimittel GmbH
    RUB 156 order
  • Gentamicin-Akos ointment 0.1% 15gSintez AKO OJSC

    122 RUR order

  • Dexa-Gentamicin eye ointment 2.5 gUrsapharm Arzneimittel GmbH

    RUB 156 order

Pharmacy Dialogue

  • Dexa-gentamicin (ointment, 2.5 g tube) Ursapharm

    RUB 141 order

  • Gentamicin-AKOS ointment (tube 0.1% 15g) Sintez (Kurgan) OJSC

    113 RUR order

  • Dexa-gentamicin (eye drops 5 ml)Ursapharm

    166 RUR order

  • Gentamicin-AKOS ointment (tube 0.1% 15g) Sintez (Kurgan) OJSC

    115 rub. order

show more

Pharmacy24

  • Gentamicin-Darnitsa 4% 2 ml No. 10 solution PrAT" Pharmaceutical company "Darnitsa", Ukraine
    28 UAH. order
  • Gentamicin sulfate 4% 2 ml No. 10 solution for injection

    36 UAH order

  • Dexa-Gentamicin 5 ml drops Ursafarm Arznaimittel GmbH, Nimecchina

    84 UAH order

PaniPharmacy

  • Gentamicin ampoule Gentamicin sulfate solution for injection 4% ampoule 2ml No. 10 Ukraine, Darnitsa ChAO

    28 UAH order

  • Gentamicin sulfate solution for eyes. 10ml Ukraine, Pharmaton

    19 UAH order

  • Dexa-gentamicin liquid Dexa-gentamicin h/c 5ml Germany, Ursapharm

    99 UAH order

  • Gentamicin ampoule Gentamicin sulfate solution for injection 4% ampoule 2ml No. 10 Ukraine, Galichfarm JSC

    43 UAH order

  • GENTAMICIN ampoule Gentamicin sulfate solution for injection 4% ampoule 2ml No. 10 Ukraine, Health LLC

    26 UAH order

show more

Rating
( 1 rating, average 4 out of 5 )
Did you like the article? Share with friends:
For any suggestions regarding the site: [email protected]
Для любых предложений по сайту: [email protected]